Endo Pharmaceuticals is recalling one lot of the prescription injectable erectile dysfunction drug Edex (alprostadil) to the consumer level due to a defect in the crimp caps that has the potential to lead to a loss of container closure integrity, which could impact the product’s sterility and lead to serious infections both at the injection site and systemically. To date, no repots of adverse events have been reported. The recall affects the 10 mcg strength of Edex (alprostadil for injection), packaged in a two-pack carton with the NDC 52244-010-02, the product lot number 207386, and the expiration date of May ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.